If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 101 - 110 of 269
A Phase 3, Open-Label, Multicenter, Randomized Study of Tarlatamab in Combination with Durvalumab vs Durvalumab Alone in Subjects with Extensive-Stage Small-Cell Lung Cancer Following Platinum, Etoposide and Durvalumab (DeLLphi-305)
Objective
Study comparing tarlatamab and durvalumab versus durvalumab alone in first-line ES-SCLC
Protocol No
AMG-757-20200041-DELLPHI-305
Categories
Sex-specific Effects of Continuous Estrogen on Human in vivo Microvascular Function
Objective
Estrogen and Microvascular Function
Protocol No
ANES-IIT-FREED-ESTROGEN
Categories
Concept Identification for MEG Aphasia
Objective
Concept Identification for MEG Aphasia
Protocol No
ANES-IIT-GROSS-CONCEPT-ID
Categories
A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients with Myeloid Malignancies
Objective
A Phase 1b/2 Study of BGB-11417 in Patients with Myeloid Malignancies
Protocol No
BEIGENE-BGB-11417-103
Categories
A Phase 1, Multicenter, Open-Label Study of CB-012, a CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AMpLify)
Objective
CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With R/R AML
Protocol No
CARIBOU-AMPLIFY-CB12A-AML
Categories
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Objective
Clinical trial of atrial fibrillation patients comparing left atrial appendage occlusion therapy to non-vitamin K antagonist oral anticoagulants
Protocol No
CVC-ABBOTT-CATALYST
Categories
Impella-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Objective
Impella-Supported PCI in Complex Coronary Artery Disease PROTECT IV
Protocol No
CVC-ABIOMED-PROTECT-IV
Categories
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Objective
AccuCinch Ventricular Restoration System in HFrEF
Protocol No
CVC-ANCORA-CORCINCH-HF
Categories
Deliver Insights in Hypertrophic Cardiomyopathy and Observational Outcomes in Real World: United States Prospective Registry Study
Objective
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Protocol No
CVC-BMS-DISCOVER-HCM
Categories
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Objective
Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
Protocol No
CVC-BOSTONSCIENTIFIC-ACURATE
Categories